Back
Brinker International Vs. Summit Therapeutics Industry Stock Comparison
Buy
75
EAT
Brinker International
Last Price:
74.12
Seasonality Move:
3.31%
Buy
79
SMMT
Summit Therapeutics
Last Price:
24.55
Seasonality Move:
26.72%
Buy
75
Brinker International (EAT)
is a Buy
Is Brinker International a Buy, Sell or Hold?
- The current Brinker International [EAT] share price is $75.19. The Score for EAT is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- EAT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
79
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $26.22. The Score for SMMT is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EAT Stock Price Chart
What is Brinker International's stock price today?
-
The Brinker International share price today is $75.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $26.22
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
EAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.31 | Buy |
Relative Strength Index (14 RSI): | 62.92 | Buy |
Chaikin Money Flow: | 1330494 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (67.42 - 72.28) | Buy |
Bollinger Bands (100): | (60.6 - 71.94) | Buy |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.4 | Buy |
Relative Strength Index (14 RSI): | 69.61 | Buy |
Chaikin Money Flow: | -7453022 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.89 - 22.53) | Buy |
Bollinger Bands (100): | (4.23 - 14.99) | Buy |
EAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 70.93 | Buy |
20-day SMA: | 70.61 | Buy |
50-day SMA: | 67.28 | Buy |
200-day SMA: | 55.17 | Buy |
8-day EMA: | 71.67 | Buy |
20-day EMA: | 70.35 | Buy |
50-day EMA: | 68.3 | Buy |
200-day EMA: | 57.54 | Buy |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.01 | Buy |
20-day SMA: | 17.36 | Buy |
50-day SMA: | 13.03 | Buy |
200-day SMA: | 6.61 | Buy |
8-day EMA: | 24.48 | Buy |
20-day EMA: | 19.28 | Buy |
50-day EMA: | 14.43 | Buy |
200-day EMA: | 8.04 | Buy |
Brinker International Earnings Growth & EAT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.22 per share, an increase this year of $1.46 per share, and an increase next year of $0.45 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Brinker International Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |